VENOFER

This brand name is authorized in United States. It is also authorized in Australia, Austria, Canada, Croatia, Cyprus, Ecuador, Estonia, Finland, France, Hong Kong SAR China, Ireland, Israel, Lithuania, Netherlands, New Zealand, Poland, Romania, Singapore, South Africa, Spain, Tunisia, Turkey, UK.

Active ingredients

The drug VENOFER contains one active pharmaceutical ingredient (API):

1	Iron sucrose UNII FZ7NYF5N8L - IRON SUCROSE
	Iron sucrose is composed of a polynuclear iron(III)-hydroxide core surrounded by a large number of non-covalently bound sucrose molecules. The polynuclear iron core has a structure similar to that of the core of the physiological iron storage protein ferritin. The complex is designed to provide, in a controlled manner, utilisable iron for the iron transport and storage proteins in the body (i.e., transferrin and ferritin, respectively).
	Read more about Iron sucrose

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
VENOFER Solution for injection	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
B03AC	Iron trivalent, parenteral preparations	B Blood and blood forming organs → B03 Antianemic preparations → B03A Iron preparations
Discover more medicines within B03AC

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	10229J, 8807M
CA	Health Products and Food Branch	02243716
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	2405-MEE-0816
EE	Ravimiamet	1133121
ES	Centro de información online de medicamentos de la AEMPS	64000
FI	Lääkealan turvallisuus- ja kehittämiskeskus	099092
FR	Base de données publique des médicaments	60080232
GB	Medicines & Healthcare Products Regulatory Agency	185386, 186794
HK	Department of Health Drug Office	50860
HR	Agencija za lijekove i medicinske proizvode	HR-H-398921872
IL	מִשְׂרַד הַבְּרִיאוּת	7259
LT	Valstybinė vaistų kontrolės tarnyba	1004161, 1091008
NL	Z-Index G-Standaard	14170965
NL	Z-Index G-Standaard, PRK	100110, 49948
NZ	Medicines and Medical Devices Safety Authority	11113
PL	Rejestru Produktów Leczniczych	100024167, 100254223, 100399720, 100418707
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W51230001, W51230002
SG	Health Sciences Authority	11354P
TN	Direction de la Pharmacie et du Médicament	8793011H
TR	İlaç ve Tıbbi Cihaz Kurumu	8699514755661
US	FDA, National Drug Code	0517-2310, 0517-2325, 0517-2340, 49230-530, 49230-534, 50090-4541
ZA	Health Products Regulatory Authority	32/8.3/0166